TMCnet News
Elixir Medical Announces Schedule of Programs for TCT 2015Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it will stream the first live transmission case demonstration of its breakthrough DESolve® Cx Novolimus Eluting Bioresorbable Coronary Scaffold System at the 27th annual Transcatheter Cardiovascular Technologies (TCT) Conference in San Francisco, California, on Monday, October 12. The Elixir Satellite Symposium is scheduled for Wednesday, October 14. Elixir will also present 3-year clinical and imaging results for its DESolve® Nx Novolimus Eluting Bioresorbable Coronary Scaffold System during the scientific conference. Following are the details of Elixir Medical's programs and activities at TCT in Pacific Time (PT): Monday, October 12:
8:45 AM, Moscone South, Esplanade Level, Main Arena
3:26 - 3:33 PM, Moscone West, 3rd Floor, Room 3001 - 3005
Tuesday, October 13:
3:45 - 4:00 PM, Moscone West, 2nd Floor, Room 2010
Poster Sessions: 4 - 6 PM, Poster Hall, Moscone West Poster 2083: Multi-Center, Randomized Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: 4-Year Results fro the EXCELLA BD Study ®
Poster 2183: Multi-Center, Post-marketing Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System: 1-Year Results from the EXCELLA PMCF Study
Poster 2178: Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study
Poster 4191: Successful revascularization of three vessel coronary disease involving a very challenging chronic total occlusion lesion with multiple DESolve
Wednesday, October 14:
1 - 2 PM, Moscone South, Lower Level, Exhibit Hall, Presentation Theater
3 Chairs
Faculty
Space is limited: Please register in advance at www.tctconference.com/satelliteprograms
7:17 - 7:24 PM Ballroom Level, Continental Ballroom 1-4
Elixir Medical will have a booth at TCT: Booth 1533, Exhibit Hall. The booth will be open Monday, October 12 through Wednesday, October 14 from 9 AM to 5 PM. About Elixir Medical Elixir Medical Corporation, a privately held company headquartered in Sunnyvale, California, develops products that combine state-of-the-art medical devices with advanced pharmaceuticals to provide innovative treatment solutions to patients worldwide. The company's next-generation drug-eluting stent systems and bioresorbable coronary scaffold are designed to optimize localized drug delivery to provide safe and effective treatments for cardiovascular patients. For more information, visit www.elixirmedical.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20151007005493/en/ |